Company intelligence / Profile preview

Arrant Bio

Waltham, MA, USA

Ownership: Private
Development stage: Other

Overview

Arrant Bio is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the advancement of mRNA-based therapeutics and vaccines. The company provides end-to-end services including sequence optimization, mRNA synthesis, and lipid nanoparticle (LNP) encapsulation. By leveraging deep expertise in RNA chemistry and formulation, Arrant Bio helps biotechnology and pharmaceutical partners accelerate their programs from discovery through clinical development. Their capabilities include process development, analytical characterization, and cGMP manufacturing.

Modalities: mRNA-based drugsLipid nanoparticle delivery therapyRNA therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Arrant Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arrant Bio.

Explore the full profile